## **Core Concept**
A newborn screening test, often referred to as a "newborn metabolic screening" or "Guthrie test," is crucial for early detection of congenital disorders. This test typically involves analyzing a blood sample obtained from the heel of the newborn. The primary goal is to identify conditions that can cause severe health problems if not treated promptly.

## **Why the Correct Answer is Right**
The correct answer, **Phenylketonuria (PKU)**, is a genetic disorder characterized by the inability of the body to break down the amino acid phenylalanine (Phe). This condition leads to the accumulation of Phe in the body, which can cause intellectual disability and other serious health problems if not treated early. The test for PKU is a critical component of newborn screening because early detection and dietary intervention can significantly improve outcomes for affected children.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain conditions related to thyroid function are screened in newborns, such as congenital hypothyroidism, this is not the primary focus of a routine newborn metabolic screening related to the question.
- **Option B:** This option seems to refer to another metabolic disorder but is not clearly specified. However, conditions like congenital adrenal hyperplasia (CAH) are indeed screened for in newborns, but this does not directly relate to the Guthrie test's primary purpose.
- **Option D:** This option does not clearly relate to a specific condition commonly screened for in newborns through metabolic testing.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Phenylketonuria (PKU)** is one of the classic conditions for which newborn screening is performed. Early detection allows for dietary restrictions to prevent intellectual disability. A common mnemonic or fact to recall is that PKU is often associated with a musty odor in the urine of affected infants due to the accumulation of phenylacetate.

## **Correct Answer:** C. Phenylketonuria.